Vitamin D Deficiency Is Inversely Associated with COVID-19 Incidence and Disease Severity in Chinese People
Xia Luo, Qing Liao, Ying Shen, Huijun Li, Liming Cheng
doi:10.1093/jn/nxaa332.1
Background: Vitamin D might have beneficial potential in influencing the natural history of the coronavirus disease 2019 (COVID-19) due to its immunomodulatory and anti-inflammatory properties.
Objective: The aim was to investigate whether vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people.
Methods : In a cross-sectional study we retrospectively analyzed 335 COVID-19 patients (median: 56.0; IQR: 43.0-64.0 y) who were admitted to the Wuhan Tongji Hospital between 27 February and 21 March 2020. We also included an age-and sex-matched population of 560 individuals (median: 55; IQR: 49.0-60.0 y) who underwent the physical examination program. Their serum 25-hydroxyvitamin D [25(OH)D] concentrations were measured during the same period from 2018-2019. Serum 25(OH)D concentrations were measured for all COVID-19 patients on admission. Severity of COVID-19 was determined based on the level of respiratory involvement. A general linear model with adjustment for covariates was used to compare 25(OH)D concentrations between the COVID-19 and 2018-2019 control groups. Adjusted ORs with 95% CIs for associations between vitamin D status and COVID-19 severity were estimated via multivariable logistic regression. Results: In the general linear model adjusted for age, sex, comorbidities, and BMI, serum 25(OH)D concentrations were significantly lower among COVID-19 patients than the 2018-2019 controls [ln transformed values of 3.32 ± 0.04 vs. 3.46 ± 0.022 ln (nmol/L), P = 0.014]. Multivariable logistic regression showed that male sex (OR: 2.26; 95% CI: 1.06, 4.82), advanced age (≥65 y) (OR: 4.93; 95% CI: 1.44, 16.9), and vitamin D deficiency (<30 nmol/L) (OR: 2.72; 95% CI: 1.23, 6.01) were significantly associated with COVID-19 severity (all P < 0.05). Conclusions: These findings suggested that vitamin D deficiency impacts COVID-19 hospitalization and severity in the Chinese population.
Fisher's exact test. 3 Information on BMI was available for 45 cases in the discharged group and 4 in the death group. 4 Including hypertension, diabetes, cardiovascular disease, cerebrovascular disease, chronic lung diseases, chronic kidney disease, and tumors. 5 Serum 25(OH)D concentrations <30 nmol/L. 6 Serum 25(OH)D concentrations ≥30 nmol/L.
References
Arnold, COVID-19-does this disease kill due to imbalance of the renin angiotensin system (RAS) caused by genetic and gender differences in the response to viral ACE 2 attack?, Heart Lung Circ
Aygun, Vitamin D can prevent COVID-19 infection-induced multiple organ damage, Naunyn Schmiedebergs Arch Pharmacol
Beard, Bearden, Striker, Vitamin D and the anti-viral state, J Clin Virol
D'avolio, Avataneo, Manca, Cusato, Nicolo et al., 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients
Garcia-Carrasco, Jimenez-Herrera, Galvez-Romero, Mendoza-Pinto, Mendez-Martinez et al., The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome, Lupus
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients
Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr
Hoe, Nathanielsz, Toh, Spry, Marimla et al., Anti-inflammatory effects of vitamin D on human immune cells in the context of bacterial infection, Nutrients
Holick, Vitamin D deficiency, N Engl J Med
Hooper, Nápoles, Pérez-Stable, COVID-19 and racial/ethnic disparities, JAMA
Kara, Ekiz, Ricci, Kara, Chang et al., Scientific strabismus" or two related pandemics: coronavirus disease and vitamin D deficiency, Br J Nutr
Levey, Stevens, Schmid, Zhang, Castro Af 3rd et al., A new equation to estimate glomerular filtration rate, Ann Intern Med
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ
Meftahi, Jangravi, Sahraei, Bahari, The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging, Inflamm Res
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D deficiency and treatment with COVID-19 incidence. medRxiv,
doi:10.1101/2020.05.08.20095893Merzon, Tworowski, Gorohovski, Vinker, Cohen et al., Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study, FEBS J
Nair, Maseeh, Vitamin D: the "sunshine" vitamin, J Pharmacol Pharmacother
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients
Rhodes, Subramanian, Laird, Kenny, Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees north supports vitamin D as a factor determining severity, Aliment Pharmacol Ther
Schwalfenberg, A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency, Mol Nutr Food Res
Science, Maguire, Russell, Smieja, Walter et al., Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents, Infect Dis
Teymoori-Rad, Shokri, Salimi, Marashi, The interplay between vitamin D and viral infections, Rev Med Virol
Verdoia, Pergolini, Nardin, Rolla, Negro et al., Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy, Vasc Pharmacol
Wang, Li, Yin, Zhang, Olsen et al., Vitamin D and chronic diseases, Aging Dis
Watkins, Lemonovich, Salata, An update on the association of vitamin D deficiency with common infectious diseases, Can J Physiol Pharmacol
Weiss, Murdoch, Clinical course and mortality risk of severe COVID-19, Lancet North Am Ed
Wong, Chan, Chan, Tse, Chim et al., Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B, Clin Gastroenterol Hepatol
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the reninangiotensin system, Mol Med Rep
Zhang, Wu, Sun, Vitamin D, vitamin D receptor, and tissue barriers, Tissue Barriers
{ 'indexed': {'date-parts': [[2024, 4, 4]], 'date-time': '2024-04-04T23:11:28Z', 'timestamp': 1712272288775},
'reference-count': 26,
'publisher': 'Elsevier BV',
'issue': '10',
'license': [ { 'start': { 'date-parts': [[2020, 10, 1]],
'date-time': '2020-10-01T00:00:00Z',
'timestamp': 1601510400000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'},
{ 'start': { 'date-parts': [[2021, 10, 1]],
'date-time': '2021-10-01T00:00:00Z',
'timestamp': 1633046400000},
'content-version': 'vor',
'delay-in-days': 365,
'URL': 'http://www.elsevier.com/open-access/userlicense/1.0/'}],
'funder': [ { 'DOI': '10.13039/100000002',
'name': 'National Institutes of Health',
'doi-asserted-by': 'publisher'},
{ 'DOI': '10.13039/100001021',
'name': 'Damon Runyon Cancer Research Foundation',
'doi-asserted-by': 'publisher'},
{ 'DOI': '10.13039/100000054',
'name': 'National Cancer Institute',
'doi-asserted-by': 'publisher'}],
'content-domain': { 'domain': ['annalsofoncology.org', 'elsevier.com', 'sciencedirect.com'],
'crossmark-restriction': True},
'published-print': {'date-parts': [[2020, 10]]},
'DOI': '10.1016/j.annonc.2020.06.007',
'type': 'journal-article',
'created': {'date-parts': [[2020, 6, 17]], 'date-time': '2020-06-17T01:47:45Z', 'timestamp': 1592358465000},
'page': '1386-1396',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 186,
'title': 'COVID-19 in patients with lung cancer',
'prefix': '10.1016',
'volume': '31',
'author': [ {'given': 'J.', 'family': 'Luo', 'sequence': 'first', 'affiliation': []},
{'given': 'H.', 'family': 'Rizvi', 'sequence': 'additional', 'affiliation': []},
{'given': 'I.R.', 'family': 'Preeshagul', 'sequence': 'additional', 'affiliation': []},
{'given': 'J.V.', 'family': 'Egger', 'sequence': 'additional', 'affiliation': []},
{'given': 'D.', 'family': 'Hoyos', 'sequence': 'additional', 'affiliation': []},
{'given': 'C.', 'family': 'Bandlamudi', 'sequence': 'additional', 'affiliation': []},
{'given': 'C.G.', 'family': 'McCarthy', 'sequence': 'additional', 'affiliation': []},
{'given': 'C.J.', 'family': 'Falcon', 'sequence': 'additional', 'affiliation': []},
{'given': 'A.J.', 'family': 'Schoenfeld', 'sequence': 'additional', 'affiliation': []},
{'given': 'K.C.', 'family': 'Arbour', 'sequence': 'additional', 'affiliation': []},
{'given': 'J.E.', 'family': 'Chaft', 'sequence': 'additional', 'affiliation': []},
{'given': 'R.M.', 'family': 'Daly', 'sequence': 'additional', 'affiliation': []},
{'given': 'A.', 'family': 'Drilon', 'sequence': 'additional', 'affiliation': []},
{'given': 'J.', 'family': 'Eng', 'sequence': 'additional', 'affiliation': []},
{'given': 'A.', 'family': 'Iqbal', 'sequence': 'additional', 'affiliation': []},
{'given': 'W.V.', 'family': 'Lai', 'sequence': 'additional', 'affiliation': []},
{'given': 'B.T.', 'family': 'Li', 'sequence': 'additional', 'affiliation': []},
{'given': 'P.', 'family': 'Lito', 'sequence': 'additional', 'affiliation': []},
{'given': 'A.', 'family': 'Namakydoust', 'sequence': 'additional', 'affiliation': []},
{'given': 'K.', 'family': 'Ng', 'sequence': 'additional', 'affiliation': []},
{'given': 'M.', 'family': 'Offin', 'sequence': 'additional', 'affiliation': []},
{'given': 'P.K.', 'family': 'Paik', 'sequence': 'additional', 'affiliation': []},
{'given': 'G.J.', 'family': 'Riely', 'sequence': 'additional', 'affiliation': []},
{'given': 'C.M.', 'family': 'Rudin', 'sequence': 'additional', 'affiliation': []},
{'given': 'H.A.', 'family': 'Yu', 'sequence': 'additional', 'affiliation': []},
{'given': 'M.G.', 'family': 'Zauderer', 'sequence': 'additional', 'affiliation': []},
{'given': 'M.T.A.', 'family': 'Donoghue', 'sequence': 'additional', 'affiliation': []},
{'given': 'M.', 'family': 'Łuksza', 'sequence': 'additional', 'affiliation': []},
{'given': 'B.D.', 'family': 'Greenbaum', 'sequence': 'additional', 'affiliation': []},
{'given': 'M.G.', 'family': 'Kris', 'sequence': 'additional', 'affiliation': []},
{'given': 'M.D.', 'family': 'Hellmann', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'reference': [ { 'key': '10.1016/j.annonc.2020.06.007_bib1',
'doi-asserted-by': 'crossref',
'first-page': '783',
'DOI': '10.1158/2159-8290.CD-20-0422',
'article-title': 'Patients with cancer appear more vulnerable to SARS-COV-2: a '
'multi-center study during the COVID-19 outbreak',
'volume': '10',
'author': 'Dai',
'year': '2020',
'journal-title': 'Cancer Discov'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib2',
'doi-asserted-by': 'crossref',
'DOI': '10.1200/JCO.2020.38.18_suppl.LBA111',
'article-title': 'Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): '
'impact of type of cancer therapy\xa0and COVID therapy on survival',
'volume': '38',
'author': 'Horn',
'year': '2020',
'journal-title': 'J\xa0Clin Oncol'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib3',
'doi-asserted-by': 'crossref',
'first-page': '894',
'DOI': '10.1016/j.annonc.2020.03.296',
'article-title': 'Clinical characteristics of COVID-19-infected cancer patients: a '
'retrospective case study in three hospitals within Wuhan, China',
'volume': '31',
'author': 'Zhang',
'year': '2020',
'journal-title': 'Ann Oncol'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib4',
'doi-asserted-by': 'crossref',
'first-page': '335',
'DOI': '10.1016/S1470-2045(20)30096-6',
'article-title': 'Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China',
'volume': '21',
'author': 'Liang',
'year': '2020',
'journal-title': 'Lancet Oncol'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib5',
'doi-asserted-by': 'crossref',
'DOI': '10.1158/2159-8290.CD-20-0596',
'article-title': 'Impact of PD-1 blockade on severity of COVID-19 in patients with lung '
'cancers',
'author': 'Luo',
'year': '2020',
'journal-title': 'Cancer Discov'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib6',
'doi-asserted-by': 'crossref',
'first-page': '1',
'DOI': '10.1186/1471-2172-9-1',
'article-title': 'HLA class I supertypes: a revised and updated classification',
'volume': '9',
'author': 'Sidney',
'year': '2008',
'journal-title': 'BMC Immunol'},
{ 'issue': '7',
'key': '10.1016/j.annonc.2020.06.007_bib7',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.cell.2020.05.015',
'article-title': 'Targets of T cell responses to SARS-CoV-2 coronavirus in humans with '
'COVID-19 disease and unexposed individuals',
'volume': '181',
'author': 'Grifoni',
'year': '2020',
'journal-title': 'Cell'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib8',
'doi-asserted-by': 'crossref',
'DOI': '10.1158/2159-8290.CD-20-0516',
'article-title': 'Case fatality rate of cancer patients with COVID-19 in a New York '
'Hospital System',
'author': 'Mehta',
'year': '2020',
'journal-title': 'Cancer Discov'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib9',
'doi-asserted-by': 'crossref',
'first-page': '268',
'DOI': '10.1038/s41571-020-0362-6',
'article-title': 'Cancer, COVID-19 and the precautionary principle: prioritizing '
'treatment during a global pandemic',
'volume': '17',
'author': 'Hanna',
'year': '2020',
'journal-title': 'Nat Rev Clin Oncol'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib10',
'doi-asserted-by': 'crossref',
'first-page': '2052',
'DOI': '10.1001/jama.2020.6775',
'article-title': 'Presenting characteristics, comorbidities, and outcomes among 5700 '
'patients hospitalized with COVID-19 in the New York City area',
'volume': '323',
'author': 'Richardson',
'year': '2020',
'journal-title': 'JAMA'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib11',
'doi-asserted-by': 'crossref',
'first-page': '1763',
'DOI': '10.1016/S0140-6736(20)31189-2',
'article-title': 'Epidemiology, clinical course, and outcomes of critically ill adults '
'with COVID-19 in New York City: a prospective cohort study',
'volume': '395',
'author': 'Cummings',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib12',
'doi-asserted-by': 'crossref',
'first-page': 'm1923',
'DOI': '10.1136/bmj.m1923',
'article-title': 'Incidence, clinical outcomes, and transmission dynamics of severe '
'coronavirus disease 2019 in California and Washington: prospective '
'cohort study',
'volume': '369',
'author': 'Lewnard',
'year': '2020',
'journal-title': 'BMJ'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib13',
'doi-asserted-by': 'crossref',
'first-page': '2012',
'DOI': '10.1056/NEJMoa2004500',
'article-title': 'Covid-19 in critically ill patients in the Seattle Region - case series',
'volume': '382',
'author': 'Bhatraju',
'year': '2020',
'journal-title': 'N\xa0Engl J Med'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib14',
'doi-asserted-by': 'crossref',
'first-page': '2163',
'DOI': '10.1056/NEJMc2009316',
'article-title': 'Universal screening for SARS-CoV-2 in women admitted for delivery',
'volume': '382',
'author': 'Sutton',
'year': '2020',
'journal-title': 'N\xa0Engl J Med'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib15',
'article-title': 'Outcome of cancer patients infected with COVID-19, including toxicity '
'of cancer treatments',
'author': 'Barlesi',
'year': '2020',
'journal-title': 'Presented at the AACR Virtual Annual Meeting'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib16',
'doi-asserted-by': 'crossref',
'DOI': '10.1038/s41591-020-0979-0',
'article-title': 'Determinants of COVID-19 disease severity in patients with cancer',
'author': 'Robilotti',
'year': '2020',
'journal-title': 'Nat Med'},
{ 'issue': '10241',
'key': '10.1016/j.annonc.2020.06.007_bib17',
'doi-asserted-by': 'crossref',
'first-page': '1907',
'DOI': '10.1016/S0140-6736(20)31187-9',
'article-title': 'Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort '
'study',
'volume': '395',
'author': 'Kuderer',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib18',
'doi-asserted-by': 'crossref',
'first-page': '405',
'DOI': '10.1016/j.healun.2020.03.012',
'article-title': 'COVID-19 illness in native and immunosuppressed states: a '
'clinical-therapeutic staging proposal',
'volume': '39',
'author': 'Siddiqi',
'year': '2020',
'journal-title': 'J\xa0Heart Lung Transplant'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib19',
'doi-asserted-by': 'crossref',
'first-page': 'e20200678',
'DOI': '10.1084/jem.20200678',
'article-title': 'The many faces of the anti-COVID immune response',
'volume': '217',
'author': 'Vardhana',
'year': '2020',
'journal-title': 'J\xa0Exp Med'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib20',
'doi-asserted-by': 'crossref',
'first-page': '1845',
'DOI': '10.1016/S0140-6736(20)31208-3',
'article-title': 'Safety, tolerability, and immunogenicity of a recombinant adenovirus '
'type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, '
'non-randomised, first-in-human trial',
'volume': '395',
'author': 'Zhu',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib21',
'doi-asserted-by': 'crossref',
'first-page': '91',
'DOI': '10.1016/j.ijid.2020.03.017',
'article-title': 'Prevalence of comorbidities and its effects in patients infected with '
'SARS-CoV-2: a systematic review and meta-analysis',
'volume': '94',
'author': 'Yang',
'year': '2020',
'journal-title': 'Int J Infect Dis'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib22',
'doi-asserted-by': 'crossref',
'first-page': '1648',
'DOI': '10.1161/CIRCULATIONAHA.120.046941',
'article-title': 'COVID-19 and cardiovascular disease',
'volume': '141',
'author': 'Clerkin',
'year': '2020',
'journal-title': 'Circulation'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib23',
'doi-asserted-by': 'crossref',
'first-page': 'm1985',
'DOI': '10.1136/bmj.m1985',
'article-title': 'Features of 20\u2009133 UK patients in hospital with covid-19 using the '
'ISARIC WHO Clinical Characterisation Protocol: prospective '
'observational cohort study',
'volume': '369',
'author': 'Docherty',
'year': '2020',
'journal-title': 'BMJ'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib24',
'doi-asserted-by': 'crossref',
'first-page': '271',
'DOI': '10.1016/j.cell.2020.02.052',
'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a '
'clinically proven protease inhibitor',
'volume': '181',
'author': 'Hoffmann',
'year': '2020',
'journal-title': 'Cell'},
{ 'issue': '25',
'key': '10.1016/j.annonc.2020.06.007_bib25',
'doi-asserted-by': 'crossref',
'first-page': '2411',
'DOI': '10.1056/NEJMoa2012410',
'article-title': 'Observational study of hydroxychloroquine in hospitalized patients with '
'Covid-19',
'volume': '382',
'author': 'Geleris',
'year': '2020',
'journal-title': 'N\xa0Engl J Med'},
{ 'key': '10.1016/j.annonc.2020.06.007_bib26',
'doi-asserted-by': 'crossref',
'first-page': 'm1849',
'DOI': '10.1136/bmj.m1849',
'article-title': 'Hydroxychloroquine in patients with mainly mild to moderate coronavirus '
'disease 2019: open label, randomised controlled trial',
'volume': '369',
'author': 'Tang',
'year': '2020',
'journal-title': 'BMJ'}],
'container-title': 'Annals of Oncology',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S092375342039894X?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S092375342039894X?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2022, 11, 17]],
'date-time': '2022-11-17T19:11:06Z',
'timestamp': 1668712266000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S092375342039894X'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 10]]},
'references-count': 26,
'journal-issue': {'issue': '10', 'published-print': {'date-parts': [[2020, 10]]}},
'alternative-id': ['S092375342039894X'],
'URL': 'http://dx.doi.org/10.1016/j.annonc.2020.06.007',
'relation': {},
'ISSN': ['0923-7534'],
'subject': ['Oncology', 'Hematology'],
'container-title-short': 'Annals of Oncology',
'published': {'date-parts': [[2020, 10]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'COVID-19 in patients with lung cancer',
'name': 'articletitle',
'label': 'Article Title'},
{'value': 'Annals of Oncology', 'name': 'journaltitle', 'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.annonc.2020.06.007',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2020 European Society for Medical Oncology. Published by Elsevier Ltd.',
'name': 'copyright',
'label': 'Copyright'}]}
